In the public stem cell banking area, Jeevan blood bank and research centre in Chennai is expanding its programme and will process its full volume of stem cell samples with Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device.
On the family banking side, the renowned companies Cordlife India and Cryobanks international are also moving to automated processing exclusively by Sepax.
Such expansion is a milestone as the majority of cord blood samples in India
will now be processed with Biosafe technology.
Olivier Waridel, CEO of the Biosafe Group, said in Basel, Switzerland: "These recent
wins [of new contracts], illustrate the potential of Biosafe's Sepax technology in the BRIC
"Biosafe demonstrates its ability to meet customer expectations through its vast portfolio of processing solutions and is committed to further support stem cell banking expansion in India together with Span Healthcare".
For further information: http://www.biosafe.ch Photo: Biochemistry from Shutterstock